TI
COLL icon

Tidal Investments’s Collegium Pharmaceutical COLL Stock Holding History

Tidal Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
5,793
-2,894
-33% -$98.9K ﹤0.01% 2437
2026
Q1 		$287K Buy
+8,687
New +$368K ﹤0.01% 2059
2025
Q4 		– Sell
-5,790
Closed -$203K – 2172
2025
Q3 		$203K Buy
+5,790
New +$201K ﹤0.01% 1936

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Tidal Investments's COLL Position: Q2 2026 in Review

Tidal Investments reduced its Collegium Pharmaceutical (COLL) stake by 33% in Q2 2026, selling an estimated $98.9K and leaving 5,793 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #2437.

Tidal Investments first reported a position in COLL in Q3 2025 and has held it in 3 quarters since. The position peaked at $287K in Q1 2026. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Tidal Investments held 5,793 shares of Collegium Pharmaceutical worth $210K as of Q2 2026.
  • Tidal Investments sold 2,894 Collegium Pharmaceutical shares in Q2 2026, an estimated $98.9K.
  • Collegium Pharmaceutical made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2437 holding.
  • Tidal Investments first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Tidal Investments's Collegium Pharmaceutical position peaked at $287K in Q1 2026.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.